Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Baxter
UBS
Mallinckrodt
Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
Julphar

Generated: May 23, 2018

DrugPatentWatch Database Preview

DEXCHLORPHENIRAMINE MALEATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dexchlorpheniramine Maleate, and when can generic versions of Dexchlorpheniramine Maleate launch?

Dexchlorpheniramine Maleate is a drug marketed by Wockhardt Bio Ag and Ani Pharms Inc and is included in two NDAs.

The generic ingredient in DEXCHLORPHENIRAMINE MALEATE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
Summary for DEXCHLORPHENIRAMINE MALEATE
Drug patent expirations by year for DEXCHLORPHENIRAMINE MALEATE
Synonyms for DEXCHLORPHENIRAMINE MALEATE
(+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1)
(+)-Chlorpheniramine maleate
(+)-CHLORPHENIRAMINE; MALEIC ACID
(|AS)-|A-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine (2Z)-2-Butenedioate
(2Z)-but-2-enedioic acid; [(3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine; maleic acid
(gamma-(4-Chlorophenyl)-pyridine-2-propyl)(dimethyl)ammonium hydrogen (Z)-maleate
(gammaS)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate
(S)-|A-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate salt
(S)-3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate
(S)-Chlorpheniramine Maleate Salt
(S)-gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine maleate salt
(Z)-but-2-enedioic acid; (3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
(Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
19141-42-5
2-[p-Chloro-|A-[2-(dimethylamino)ethyl]benzyl]pyridine Maleate
2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-, (S)-, (Z)-2-butenedioate (1:1)
2438-32-6
438D326
AC-19009
AC1NQXZE
AC1Q71E6
ACM2438326
AKOS015962825
AN-20814
AS-17464
B10YD955QW
C 4915
C07783
CCG-101121
CHEBI:4465
CHEMBL1200927
Chlorpheniramine d-form maleate
CPD000471617
CS-4618
d-Chlorpheniramine maleate
d-Chlorpheniramine maleate (JP17)
D00668
D05ZGQ
DB09555
DBAKFASWICGISY-DASCVMRKSA-N
Dexchloropheniramine maleate
Dexchlorpheniramine (maleate)
Dexchlorpheniramine maleate (USP)
Dexchlorpheniramine maleate [USP]
Dexchlorpheniramine maleate, European Pharmacopoeia (EP) Reference Standard
Dexchlorpheniramine maleate, United States Pharmacopeia (USP) Reference Standard
DEXCHLORPHENIRAMINEMALEATE
Dexchlorpheniraminmaleat
Dextrochlorpheniramine maleate
EINECS 219-450-6
EU-0100264
HE020588
HMS2052E15
HMS2233I15
HMS3260F10
HY-B1062
LP00264
MFCD00079046
MLS001401384
MolPort-003-940-748
Mylaramine (TN)
NC00371
NCGC00093722-01
NCGC00093722-02
NCGC00093722-03
NCGC00260949-01
Polamin
polar amine
Polaramine
Polaramine (TN)
Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1), (+)-
Rescon JR
Rescon MX
S-(+)-Chlorpheniramine maleate
S-(+)-Chlorpheniramine maleate salt
SAM001246557
SCHEMBL119500
SMR000471617
Tox21_500264
UNII-B10YD955QW
UNII-V1Q0O9OJ9Z component DBAKFASWICGISY-DASCVMRKSA-N
V0236

US Patents and Regulatory Information for DEXCHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Bio Ag DEXCHLORPHENIRAMINE MALEATE dexchlorpheniramine maleate SYRUP;ORAL 088251-001 Mar 23, 1984 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc DEXCHLORPHENIRAMINE MALEATE dexchlorpheniramine maleate TABLET;ORAL 088682-001 Jan 17, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Boehringer Ingelheim
Fish and Richardson
Teva
McKinsey
Merck
Johnson and Johnson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.